Abstract
ABSTRACTObjectiveTo describe the reusable transformation process of electronic health records (EHR), claims, and prescriptions data into Observational Medical Outcome Partnership (OMOP) common data model (CDM), together with challenges faced and solutions implemented.Materials and MethodsWe used Estonian national health databases that store almost all residents’ claims, prescriptions, and EHR records. To develop and demonstrate the transformation process of Estonian health data to OMOP CDM, we used a 10% random sample of the Estonian population (n = 150,824 patients) from 2012-2019. For the sample, complete information from all three databases was converted to OMOP CDM version 5.3. The validation was performed using open-source tools.ResultsIn total, we transformed over 100 million entries to standard concepts using standard OMOP vocabularies with the average mapping rate 95%. For conditions, observations, drugs, and measurements, the mapping rate was over 90%. In most cases, SNOMED Clinical Terms were used as the target vocabulary.DiscussionDuring the transformation process, we encountered several challenges, which are described in detail with concrete examples and solutions.ConclusionFor a representative 10% random sample, we successfully transferred complete records from three national health databases to OMOP CDM and created a reusable transformation process. Our work helps future researchers to transform linked databases into OMOP CDM more efficiently, ultimately leading to better real-world evidence.
Publisher
Cold Spring Harbor Laboratory
Reference41 articles.
1. Hubbard T , Paradis R. Real world evidence: a new era for health care innovation. NEHI - Network for Excellence in Health Innovation 2015. https://www.nehi-us.org/writable/publication_files/file/rwe_issue_brief_final.pdf
2. Real-World Evidence — What Is It and What Can It Tell Us?
3. Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. Guidance for Industry and Food and Drug Administration Staff. 2017.https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devices
4. A review of uses of health care utilization databases for epidemiologic research on therapeutics
5. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献